Literature DB >> 3111968

Leukotrienes as mediators in frog virus 3-induced hepatitis in rats.

W Hagmann, A M Steffan, A Kirn, D Keppler.   

Abstract

The role of leukotrienes was investigated in frog virus 3-induced hepatitis in rats. Frog virus 3 elicited an enhanced generation of cysteinyl leukotrienes in vivo as monitored by measurement of N-acetyl-leukotriene E4 as the major endogenous metabolite of cysteinyl leukotrienes secreted into rat bile. N-Acetyl-leukotriene E4 concentrations were elevated for more than 4 hr after frog virus 3 injection. In vitro experiments using cultured rat liver Kupffer cells of high purity indicated that these cells can produce and metabolize leukotrienes and are thus a possible source of leukotrienes elicited in vivo by frog virus 3. The selective 5-lipoxygenase inhibitor AA 861 and the dual inhibitor of arachidonate lipoxygenase and cyclooxygenase, BW 755C, reduced the hepatocellular injury after a high dose of frog virus 3 by about 50 and 80%, respectively, as judged from plasma activities of ALT and sorbitol dehydrogenase at 24 hr after frog virus 3 administration. Our in vivo and in vitro studies argue in favor of an important role of leukotrienes as mediators in frog virus 3 hepatitis in rats.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3111968     DOI: 10.1002/hep.1840070419

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  17 in total

Review 1.  The pharmacology of ebselen.

Authors:  M J Parnham; S Leyck; E Graf; E J Dowling; D R Blake
Journal:  Agents Actions       Date:  1991-01

Review 2.  [The Heinrich-Wieland Prize presentation. Metabolism and analysis of leukotrienes in vivo].

Authors:  D Keppler
Journal:  Klin Wochenschr       Date:  1988-10-17

3.  Arachidonic acid metabolites in carbon tetrachloride-induced liver injury.

Authors:  N Kawada; Y Mizoguchi; K Kobayashi; S Yamamoto; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1990-06

4.  The immunosuppressive effects of a leukotriene B4 receptor antagonist on liver allotransplantation in rats.

Authors:  T Ii; R Izumi; K Shimizu
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

5.  Synergism between hepatic injuries and a nonhepatotropic reovirus in mice. Enhanced hepatic infection and death.

Authors:  D A Piccoli; C L Witzleben; C J Guico; A Morrison; D H Rubin
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

6.  Hepatic uptake and metabolic disposition of leukotriene B4 in rats.

Authors:  W Hagmann; M Korte
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

7.  Production of leukotriene B4 in parenchymal and sinusoidal cells of the liver in rats treated simultaneously with D-galactosamine and endotoxin.

Authors:  Y Shiratori; H Moriwaki; Y Muto; H Onishi; M Kato; F Asano
Journal:  Gastroenterol Jpn       Date:  1989-12

8.  Arachidonate metabolism in D-galactosamine or carbon tetrachloride-induced acute and chronic liver injuries in rats.

Authors:  P Liu; N Kawada; Y Mizoguchi; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1992-10

9.  Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat.

Authors:  C Denzlinger; M Grimberg; A Kapp; C Haberl; W Wilmanns
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

10.  Poxvirus-induced alteration of arachidonate metabolism.

Authors:  G J Palumbo; W C Glasgow; R M Buller
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.